BRPI0913377A2 - regime de dosagem - Google Patents

regime de dosagem

Info

Publication number
BRPI0913377A2
BRPI0913377A2 BRPI0913377A BRPI0913377A BRPI0913377A2 BR PI0913377 A2 BRPI0913377 A2 BR PI0913377A2 BR PI0913377 A BRPI0913377 A BR PI0913377A BR PI0913377 A BRPI0913377 A BR PI0913377A BR PI0913377 A2 BRPI0913377 A2 BR PI0913377A2
Authority
BR
Brazil
Prior art keywords
dosage regimen
regimen
dosage
Prior art date
Application number
BRPI0913377A
Other languages
English (en)
Inventor
Edward J Yurkow
Umesh Shukla
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0913377A2 publication Critical patent/BRPI0913377A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BRPI0913377A 2008-06-03 2009-05-29 regime de dosagem BRPI0913377A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5837608P 2008-06-03 2008-06-03
PCT/US2009/045658 WO2009148954A2 (en) 2008-06-03 2009-05-29 Dosing regimen

Publications (1)

Publication Number Publication Date
BRPI0913377A2 true BRPI0913377A2 (pt) 2015-11-24

Family

ID=41262127

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913377A BRPI0913377A2 (pt) 2008-06-03 2009-05-29 regime de dosagem

Country Status (13)

Country Link
US (1) US20090311344A1 (pt)
EP (1) EP2307041B1 (pt)
JP (1) JP2011523661A (pt)
KR (1) KR20110015448A (pt)
CN (1) CN102056616A (pt)
AU (1) AU2009256465B2 (pt)
BR (1) BRPI0913377A2 (pt)
CA (1) CA2726603A1 (pt)
ES (1) ES2729622T3 (pt)
IL (2) IL209370A0 (pt)
MX (1) MX2010013281A (pt)
WO (1) WO2009148954A2 (pt)
ZA (1) ZA201009096B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2781475T3 (es) * 2002-09-18 2020-09-02 Janssen Pharmaceuticals Inc Métodos para aumentar la producción de células madre hematopoyéticas y plaquetas
CN102321168B (zh) * 2011-08-17 2013-05-01 山东泉港药业有限公司 新型血小板生成素拟肽复性和纯化方法
WO2013070908A1 (en) * 2011-11-09 2013-05-16 Fibrogen, Inc. Therapeutic method
WO2013142328A1 (en) * 2012-03-23 2013-09-26 The Trustees Of The University Of Pensylvania Small molecule antagonists of pf4 containing ultra large complexes
JP6301011B2 (ja) 2015-03-31 2018-03-28 シスメックス株式会社 尿分析システム、撮像装置、および尿分析方法
SMT202100712T1 (it) 2015-08-17 2022-01-10 Kura Oncology Inc Metodi di trattamento di pazienti di cancro con inibitori di farnesil trasferasi
TW201818965A (zh) 2016-11-03 2018-06-01 美商庫拉腫瘤技術股份有限公司 以法呢基轉移酶（ｆａｒｎｅｓｙｌ ｔｒａｎｓｆｅｒａｓｅ）抑制劑治療癌症病患之方法
AU2018306329B8 (en) 2017-07-26 2025-02-20 Janssen Pharmaceutica Nv Methods of protecting vascular integrity induced by targeted radiation therapy
US20210322508A1 (en) * 2018-08-13 2021-10-21 Signablok, Inc. Peptides and compositions for targeted treatment and imaging
MX2021008943A (es) 2019-01-25 2021-11-04 Janssen Pharmaceutica Nv Metodos para mitigar la lesion hepatica y promover la hipertrofia hepatica, la regeneracion e injerto celular en conjunto con tratamientos de radiacion y/o radiomimeticos.
EP3914286B1 (en) 2019-01-25 2025-05-07 Janssen Pharmaceutica NV Methods of mitigating toxic effects of vesicants and caustic gas
WO2020154637A1 (en) 2019-01-25 2020-07-30 Janssen Pharmaceutica Nv Methods of enhancing protection against organ and vascular injury, hematopoietic recovery and survival in response to total body radiation/chemical exposure
WO2023056444A1 (en) 2021-10-01 2023-04-06 Janssen Pharmaceutica N.V. Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251864B1 (en) * 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7723295B2 (en) * 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor
SG131110A1 (en) * 2003-08-28 2007-04-26 Ortho Mcneil Pharm Inc Peptides and compounds that bind to thrombopoietin receptors
US7615533B2 (en) * 2004-08-16 2009-11-10 Janssen Pharmaceutica N.V. TPO peptide compounds for treatment of anemia
DK1984014T3 (da) * 2006-02-14 2014-09-15 Janssen Pharmaceutica Nv Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi

Also Published As

Publication number Publication date
CA2726603A1 (en) 2009-12-10
KR20110015448A (ko) 2011-02-15
WO2009148954A3 (en) 2010-02-04
IL209370A0 (en) 2011-01-31
WO2009148954A2 (en) 2009-12-10
ES2729622T3 (es) 2019-11-05
ZA201009096B (en) 2012-05-01
JP2011523661A (ja) 2011-08-18
AU2009256465B2 (en) 2015-05-14
US20090311344A1 (en) 2009-12-17
IL234296B (en) 2021-12-01
MX2010013281A (es) 2010-12-21
AU2009256465A1 (en) 2009-12-10
EP2307041A2 (en) 2011-04-13
CN102056616A (zh) 2011-05-11
EP2307041B1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
BRPI0913377A2 (pt) regime de dosagem
BRPI0920521A2 (pt) combinação farmacêutica
BRPI0912271A2 (pt) co-autoria estruturada
SI3199172T1 (sl) Odmerni režim za multiplo sklerozo
BRPI0823297A2 (pt) Garrafa
BRPI0913913A2 (pt) regime de dosagem para nitrocatecóis
EP2197448A4 (en) dosing schedule
DK2272763T3 (da) Blisterpakning-dispensermaskine
DK2271618T3 (da) Farmaceutiske forbindelser
IT1390848B1 (it) Composti farmaceutici
DE602008002548D1 (de) Verpackungsanordnung
TH91873B (th) ขวด
FR2928348B1 (fr) Deblisterage de blister
FI20086216A0 (fi) Pakkausjärjestely
BRPI0920534A2 (pt) conjunto transportador
FI20086100A0 (fi) Työasema
UA17688S (uk) Таблеткова вмістина
UA19304S (uk) Упаковка
UA19977S (uk) Упаковка
UA19362S (uk) Упаковка
UA18789S (uk) Упаковка
UA17677S (uk) Упаковка
UA17353S (uk) Упаковка
CN301260963S (zh) 瓶子
CN301175543S (zh) 瓶子

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL